Axcella Health, Inc

Quick facts

Phase 2 pipeline

• AXA1125 · Hepatology/Metabolic Disease
  AXA1125 is a composition of amino acids and metabolites designed to restore metabolic balance and improve liver function in patients with metabolic dysfunction.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Axcella Health, Inc portfolio CI brief
• Axcella Health, Inc pipeline updates RSS